CompaniesOtherUpdated Oct 12, 2026
Vinci Pharmaceuticals
Private. Vinci Pharmaceuticals is a specialty ophthalmic pharmaceutical company motivated to disrupt the treatment of retinal diseases with novel, next generation platform technologies.
- Last round
- $8M Series A
- Backed by
- Dynagrow Capital
- Launched
- Not recorded
- People
- 2
Overview
Updated Oct 12, 2026
Every fact carries a numbered source. Where we can't source something, it says so.
Identity fields from the company record are sourced where a source is recorded; those have no number.
- Headquarters
- Avon By The Sea, New Jersey · as of 2026-10-091
- Website
- vincipharmaceuticals.com opens in a new tab · as of 2026-10-091
- Stage
- Series A · as of 2026-10-082
- Total raised
- more than $16.5M · as of 2026-10-082
- Sector
- Not recorded
- Geography
- Avon By The Sea, New Jersey
- Founded
- Not recorded
Funding
How much has Vinci Pharmaceuticals raised?
Rounds and backers, each sourced.
Opportunities For accredited investors
Ways to invest in this company through an Alphaneo vehicle, when one exists. This section looks the same on every company page until you have an accredited profile.
Opportunities, terms and data rooms are shown to accredited investors. Creating a profile takes two minutes, and you’re notified first when anything opens.
No live opportunities right now. Accredited investors are notified first when one opens.
Create an accredited profileA vehicle is never smaller than $1,000,000.
People
Who founded and leads Vinci Pharmaceuticals?
Names and titles only, each sourced.
Sources
Every claim on this page traces to one of these. The numbers match the citations above.
- 1Vinci Pharmaceuticals: Home opens in a new tabHeadquarters, Website, People · accessed Oct 12, 2026
- 2Vinci Pharmaceuticals Inc. Closes More Than $8 Million Series A Financing to Advance EPIPLANT Drug Delivery Platform opens in a new tabStage, Total raised, Funding, People · accessed Oct 12, 2026